about
Investigational drugs for the management of Huntington's disease: are we there yet?Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches.Antipsychotic drugs in Huntington's disease.Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases.Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The pridopidine paradox in Huntington's disease.
@en
The pridopidine paradox in Huntington's disease.
@nl
type
label
The pridopidine paradox in Huntington's disease.
@en
The pridopidine paradox in Huntington's disease.
@nl
prefLabel
The pridopidine paradox in Huntington's disease.
@en
The pridopidine paradox in Huntington's disease.
@nl
P2860
P356
P1433
P1476
The pridopidine paradox in Huntington's disease.
@en
P2860
P304
P356
10.1002/MDS.25559
P407
P577
2013-07-11T00:00:00Z